Graviss EA - Search Results

1

Foxp3+ regulatory T cells in antiretroviral-naive HIV patients.

Montes M, Lewis DE, Sanchez C, Lopez de Castilla D, Graviss EA, Seas C, Gotuzzo E, White AC Jr. Montes M, et al. Among authors: graviss ea. AIDS. 2006 Aug 1;20(12):1669-71. doi: 10.1097/01.aids.0000238415.98194.38. AIDS. 2006. PMID: 16868450

2

Clinical prediction model for differentiation of disseminated Histoplasma capsulatum and Mycobacterium avium complex infections in febrile patients with AIDS.

Graviss EA, Vanden Heuvel EA, Lacke CE, Spindel SA, White AC Jr, Hamill RJ. Graviss EA, et al. J Acquir Immune Defic Syndr. 2000 May 1;24(1):30-6. doi: 10.1097/00126334-200005010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 10877492

3

Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic.

Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, Lahart CJ, Visnegarwala F. Giordano TP, et al. Among authors: graviss ea. J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):399-405. doi: 10.1097/00126334-200304010-00009. J Acquir Immune Defic Syndr. 2003. PMID: 12640198

4

Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?

Giordano TP, Wright JA, Hasan MQ, White AC Jr, Graviss EA, Visnegarwala F. Giordano TP, et al. Among authors: graviss ea. Clin Infect Dis. 2003 Aug 1;37(3):433-7. doi: 10.1086/376638. Epub 2003 Jul 16. Clin Infect Dis. 2003. PMID: 12884169

5

Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?

Visnegarwala F, Graviss EA, Sajja P, Lahart CJ, White AC Jr. Visnegarwala F, et al. Among authors: graviss ea. HIV Clin Trials. 2004 May-Jun;5(3):117-24. doi: 10.1310/JQ8U-6KVB-9JCG-JL51. HIV Clin Trials. 2004. PMID: 15248135

6

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ. Shelburne SA, et al. Among authors: graviss ea. AIDS. 2005 Mar 4;19(4):399-406. doi: 10.1097/01.aids.0000161769.06158.8a. AIDS. 2005. PMID: 15750393

7

Epidemiology of neurocysticercosis in Houston, Texas.

del la Garza Y, Graviss EA, Daver NG, Gambarin KJ, Shandera WX, Schantz PM, White AC Jr. del la Garza Y, et al. Among authors: graviss ea. Am J Trop Med Hyg. 2005 Oct;73(4):766-70. Am J Trop Med Hyg. 2005. PMID: 16222023

8

Seropositive human subjects produce interferon gamma after stimulation with recombinant Cryptosporidium hominis gp15.

Preidis GA, Wang HC, Lewis DE, Castellanos-Gonzalez A, Rogers KA, Graviss EA, Ward HD, White AC Jr. Preidis GA, et al. Among authors: graviss ea. Am J Trop Med Hyg. 2007 Sep;77(3):583-5. Am J Trop Med Hyg. 2007. PMID: 17827383

9

Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis.

Feske M, Nudelman RJ, Medina M, Lew J, Singh M, Couturier J, Graviss EA, Lewis DE. Feske M, et al. Among authors: graviss ea. Clin Vaccine Immunol. 2008 Oct;15(10):1616-22. doi: 10.1128/CVI.00185-08. Epub 2008 Aug 27. Clin Vaccine Immunol. 2008. PMID: 18753334 Free PMC article.

10

Contemporary neurosurgical approaches to neurocysticercosis.

Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan P, White AC Jr. Rangel-Castilla L, et al. Among authors: graviss ea. Am J Trop Med Hyg. 2009 Mar;80(3):373-8. Am J Trop Med Hyg. 2009. PMID: 19270284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters